Allergan names Jim Hindman chief financial officer

Allergy specialist Allergan (NYSE: AGN) has appointed Jim Hindman as chief financial officer, effective immediately, replacing Jeff Edwards. Mr Hindman (pictured) has worked for Allergan since 1984 and has served as senior vice president, treasury, risk and investor relations since 2002. Prior to this, he has held various financial positions in the company, and elsewhere, including Deloitte.

David Pyott, Allergan’s chief executive officer, said: "We are pleased to name Jim Hindman as Allergan's chief financial officer. Jim has been an instrumental member of our organization for many years, and particularly during the past few months, has played an important leadership role. We believe that Jim is ideally suited to assume the position of chief financial officer and we are confident that his long tenure and experience in our finance organization, together with his strong record as a leader in the company, will be invaluable as he assumes his new role."

Mr Hindman said: "I am excited to take on this new role and I look forward to working with David, the board of directors and Allergan's talented employees as we continue our focus on delivering enhanced value to stockholders."